Vermont
How Enright v. Eli Lilly & Co. applies in Vermont: state-specific rules, key cases, and bar exam notes for Other.
Vermont follows a robust application of the principles established in Enright v. Eli Lilly & Co. regarding the liability of pharmaceutical manufacturers for defective products. The state upholds the necessity for plaintiffs to prove both harm and causation, aligning closely with the precedent set by this case.
In Vermont, plaintiffs must demonstrate that a pharmaceutical product was defectively designed or manufactured, and that this defect was the proximate cause of their injuries, as established by Enright.
The Vermont Supreme Court affirmed that strict product liability claims require proof of defect and causation, reflecting principles from Enright.
The court held that manufacturers could be liable for design defects if they fail to meet consumer expectations, thus linking to the consumer-oriented approach of Enright.
In this case, the court reiterated the necessity of proving that the product's defect directly caused the injury, reiterating a standard seen in Enright.
Vermont's approach aligns closely with the federal standard under the Restatement (Second) of Torts, emphasizing proof of defect and causation. However, Vermont courts tend to apply a more consumer-friendly perspective, potentially broadening the scope of liability compared to federal benchmarks.
Understanding the application of strict liability in pharmaceutical cases, especially as illustrated by Enright, is crucial for the Vermont bar exam, highlighting the intersection of tort law and product liability.